Single centre, open, controlled, randomised (1:1), parallel group: insulin glargine vs. NPH [insulin suspension isophane]: FPG (fasting plasma glucose) in patients with DM type 1 [type 1 diabetes mellitus] who skip the morning meal during treatment with MDI (mulitple daily injection) basal/bolus insulin
Phase of Trial: Phase IV
Latest Information Update: 13 Oct 2009
At a glance
- Drugs Insulin glargine; Insulin suspension isophane
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SAM
- Sponsors Sanofi
- 07 Jul 2009 Actual initiation date changed from Oct 2001 to Nov 2001 as reported by ClinicalTrials.gov.
- 13 Sep 2006 New trial record.